New York State Common Retirement Fund’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$386K Buy
21,218
+8,300
+64% +$123K ﹤0.01% 2110
2026
Q1
$184K Hold
12,918
﹤0.01% 2267
2025
Q4
$134K Hold
12,918
﹤0.01% 2477
2025
Q3
$76.6K Hold
12,918
﹤0.01% 2781
2025
Q2
$97.3K Hold
12,918
﹤0.01% 2690
2025
Q1
$97.8K Hold
12,918
﹤0.01% 2529
2024
Q4
$157K Buy
12,918
+3,200
+33% +$46K ﹤0.01% 2406
2024
Q3
$163K Sell
9,718
-6,100
-39% -$108K ﹤0.01% 2391
2024
Q2
$276K Buy
15,818
+6,308
+66% +$134K ﹤0.01% 2289
2024
Q1
$162K Buy
9,510
+2,824
+42% +$43.6K ﹤0.01% 2536
2023
Q4
$68.1K Sell
6,686
-71
-1% -$629 ﹤0.01% 2898
2023
Q3
$61.2K Buy
6,757
+52
+0.8% +$542 ﹤0.01% 2948
2023
Q2
$72.1K Sell
6,705
-7,548
-53% -$80.2K ﹤0.01% 3038
2023
Q1
$146K Sell
14,253
-8,814
-38% -$97.2K ﹤0.01% 2712
2022
Q4
$243K Buy
23,067
+4
+0% +$49 ﹤0.01% 2642
2022
Q3
$296K Buy
23,063
+5,479
+31% +$73.8K ﹤0.01% 2595
2022
Q2
$225K Buy
17,584
+1,734
+11% +$19.7K ﹤0.01% 2742
2022
Q1
$166K Sell
15,850
-575
-4% -$7.77K ﹤0.01% 2878
2021
Q4
$253K Buy
16,425
+4,577
+39% +$91.3K ﹤0.01% 2780
2021
Q3
$267K Buy
11,848
+44
+0.4% +$1.18K ﹤0.01% 2782
2021
Q2
$304K Buy
11,804
+3,404
+41% +$105K ﹤0.01% 2840
2021
Q1
$350K Buy
+8,400
New +$341K ﹤0.01% 2624

Other funds holding CGEM

New York State Common Retirement Fund's CGEM Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Cullinan Oncology (CGEM) stake by 64% in Q2 2026, buying an estimated $123K and bringing the position to 21,218 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

New York State Common Retirement Fund first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. 34 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • New York State Common Retirement Fund held 21,218 shares of Cullinan Oncology worth $386K as of Q2 2026.
  • New York State Common Retirement Fund bought 8,300 Cullinan Oncology shares in Q2 2026, an estimated $123K.
  • Cullinan Oncology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2110 holding.
  • New York State Common Retirement Fund first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • 34 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.